| Characterization of in vitro procoagulant mechanisms of the human glioblastoma cell line, A172 |
|
2008 |
| Procoagulant properties of melanoma microvesicles suggest their involvement in cancer-associated thrombosis |
|
2008 |
| The insect-derived lipocalin, nitrophorin 2, is a potent antithrombotic agent |
|
2008 |
| Targeting the procoagulant properties of glioma cells: a possible treatment for glioblastoma? |
|
2007 |
| Malignant transformation in melanocytes increases the production of procoagulant microvesicles |
|
2007 |
| Antitumor effect of ixolaris, a FVIIa/tissue factor complex inhibitor, in B16F10 melanoma |
|
2007 |
| Serpin-independent anticoagulant activity of sulfated polysaccharides from marine organisms |
|
2007 |
| Immunity, thrombosis and survival in lung adenocarcinoma patients: a prospective study |
|
2007 |
| Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris |
|
2007 |
| Increased expression of tissue factor, PAR-1 and interleukin-8 in esophageal cancer patients |
|
2007 |
| Correlation of thrombosis and prothrombotic markers with survival in lung adenocarcinoma patients: a prospective study |
|
2007 |
| Human MV3 melanoma cells display an unusual mechanism for procoagulant activity |
|
2006 |
| Blood coagulation proteins in cancer: increased expression of Tissue Factor and PAR-1 in esophageal cancer |
|
2006 |
| Anticoagulant and antithrombotic properties of Anophelin, a novel anti-thrombin molecule |
|
2006 |
| Sulfated galactan and heparin differ in their preferred pathway of polysaccharide-accelerated inactivation of thrombin by antithrombin |
|
2006 |
| A serpin independent inhibition of coagulation by sulfated polysaccharides from marine organisms |
|
2006 |
| Structural basis for thrombin inhibition by suramin |
|
2006 |
| Counteracting effect of glycyrrhizin on the haemostatic abnormalities induced by Bothrops jararaca snake venom |
|
2006 |
| Putative immunosupressive role of phosphatidylserine-exposing vesicles from B16F10 cells in malignant melanoma establishment |
|
2006 |
| Inhibition of platelet aggregation by a fucosylated chondroitin sulfate from a sea cucumber |
|
2006 |
| Procoagulant activity of three different types of leukemic cell lines |
|
2006 |
| Increased Expression of TF and PAR-1 in esophageal cancer patients |
|
2005 |
| Rat C6 Glioma Cells Express Tissue Factor and Strongly Assemble Blood Procoagulant Complexes |
|
2005 |
| Expression of tissue factor in human monocytes infected by Dengue 2 virus-A possible role in Dengue hemorrhagic fever? |
|
2005 |
| Heparin cofactor II-independent antithrombotic activity of ascidian dermatan sulfates in an arterial thrombosis model in rats |
|
2005 |
| Fucosylated chondroitin sulfate prevents thrombin- and collagen-induced platelet aggregation |
|
2005 |
| Calcium enhances sulfated galactan catalysis of the antithrombin-factor Xa inhibition reaction by a bridging mechanism |
|
2005 |
| The anticoagulant action of a sulfated galactan starts by its initial binding to thrombin instead of antithrombin |
|
2005 |
| Occupancy of active site promotes specific structural and thermodynamic changes in human thrombin |
|
2005 |
| Anticoagulant and Antithrombotic Properties of Ixolaris, a Novel Recombinant FVIIa-Tissue Factor Inhibitor |
|
2005 |
| The Effect of Glycyrrhizin against the Pro-Hemostatic Activities of Bothrops jararaca Snake Venom |
|
2005 |
| Antithrombotic effect of Bothrojaracin, a Bothrops jararaca snake venom-derived (pro)thrombin inhibitor |
|
2005 |
| Prothrombin Fragments Interfere in Human Neutrophil Migration by Modulating Grk-2 and IL-8 Expression |
|
2005 |
| Antithrombotic effect of Bothrojaracin, a snake-derived (pro)thrombin inhibitor |
|
2005 |
| Procoagulant pattern of rat C6 glioma cells: a new model for studying the role of blood coagulation proteins in tumor biology |
|
2005 |
| Platelet activating factor disturbs interkinetic nuclear migration by induction of a checkpoint in the S/G2 transition of the cell cycle in the developing retina |
|
2005 |
| Monocyte activation after Dengue Virus infection: Toll-Like Receptor, Inducible Nitric Oxide Synthase, Bcl-2 and Tissue Factor expression |
|
2005 |
| Blood coagulation proteins in cancer: molecular mechanisms for the highly procoagulant pattern of C6 glioma cells |
|
2005 |
| Blood coagulation proteins in cancer: increased expression of tissue factor and PAR-1 in esophageal cancer |
|
2005 |
| Jarastatin, a Bothrops jararaca venom-derived peptide, is a potent inhibitor of human platelet aggregation |
|
2005 |
| Rat C6 Glioma Cells Express Tissue Factor and Strongly Assemble Blood Procoagulant Complexes |
|
2005 |
| Characterization of procoagulant activity of a human melanoma cell line ? WM-266-4 |
|
2005 |
| Propriedades antitrombóticas do Ixolaris, um novo inibidor da via do fator tecidual |
|
2005 |
| Comparative study of snake venoms using maldi tof mass spectrometry as a tool to investigate low mass peptides in complex samples |
|
2004 |
| Ixolaris inhibits tumor-assembled procoagulant enzymatic complexes |
|
2004 |
| Ixolaris: a factor Xa heparin-binding exosite inhibitor |
|
2004 |
| Prothrombin is chemotactic for human neutrophils in a process involving the PKC pathway |
|
2004 |
| Antithrombotic effect of Bothrojaracin, a Bothrops jararaca snake venom-derived (pro)thrombin inhibitor |
|
2004 |
| The effect of Glycyrrhizin against Bothrops jararaca snake venom: evaluation of in vivo pro-hemostatic activities |
|
2004 |
| The effect of Suramin against Bothrops jararaca snake venom: evaluation of in vivo pro-hemostatic activities |
|
2004 |
| Nitric oxide synthase is down-regulated during infection of Rhodnius prolixus salivary glands by Trypanosoma rangeli |
|
2003 |
| Platelet activating factor disturbs interkinetic nuclear migration by induction of a checkpoint in the S/G2 transition of the cell cycle in the developing retina |
|
2003 |
| Platelet activating factor disturbs interkinetic nuclear migration in the developing retina |
|
2003 |
| Prothrombinase complex assembly on B16F10 melanoma cells |
|
2003 |
| Stimulation of differentiation and infectivity of Trypanosoma cruzi by intrinsic lipid |
|
2003 |
| Assembly and regulation of prothrombinase complex on B16F10 melanoma cells |
|
2003 |
| Unfolding, subunit dissociation, and inactivation of C-type lectin-like proteins from snake venom |
|
2002 |
| Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation |
|
2002 |
| Anti-Hemostatic Activities Of Rhodnius prolixus Salivary Glands' Phospholipids. |
|
2002 |
| Antithrombotic effect of glycirrhizin |
|
2002 |
| Stimulation of Leishmania amazonensis and Trypanosoma cruzi infectivity by an intrinsic lipid |
|
2002 |
| Characterization of bothrojaracin interaction with human prothrombin |
|
2001 |
| Characterization of bothrojaracin interaction with human prothrombin |
|
2001 |
| Purification and partial characterization of a C-type Lectin from Bothrops insularis venom |
|
2001 |
| Antithrombotic activity of glycyrrhizin |
|
2001 |
| Bothrojaracin interaction with prothrombin |
|
2001 |
| Bothrojaracin, a thrombin inhibitor from Bothrops jararaca venom: mechanism of action and structural aspects |
|
2000 |
| Purification and partial characterization of a C-type lectin from Bothrops insularis venom |
|
2000 |
| Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom |
|
2000 |
| Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom |
|
2000 |
| Bothrojaracin, a C-type lectin from Bothrops jararaca venom, inhibits prothrombin activation |
|
2000 |
| Characterization of the ecotin interaction with thrombin |
|
2000 |
| Distinct mechanisms of Urea- and High hydrostatic pressure-induced unfolding of human-a-thrombin |
|
1999 |
| Structural studies of bothrojaracin, a C-type lectin from Bothrops jararaca snake venom |
|
1999 |
| Allosteric changes on thrombin catalytic site induced by interaction with anion-binding exosites I and II |
|
1999 |
| Biological properties of Bothrops insularis (jararaca Ilhoa) venom on blood components |
|
1998 |
| Bothrojaracin interaction with thrombin exosite I plays a major role in the allosteric changes of thrombin's catalytic site |
|
1998 |
| Bothrojaracin produces allosteric changes on thrombin's catalytic site |
|
1998 |
| Proteolytic action of Bothrops jararaca venom upon its own constituents |
|
1998 |
| Effect of Bothrops insularis venom on blood components |
|
1998 |
| Bothrojaracin, a thrombin inhibitor isolated from Bothrops jararaca venom, binds to thrombin's anion-binding exosite producing conformational changes in its catalytic site |
|
1997 |
| Identification of glycyrrhizin as a thrombin inhibitor |
|
1997 |
| Kinetic parameters of anticoagulant activities of low molecular weight heparin (LMWH) |
|
1997 |
| Ação proteolítica do veneno da serpente Bothrops jararaca (jararaca) em seus próprios constituintes |
|
1997 |
| Bothrops jararaca snakes produce several bothrojaracin isoforms following an individual pattern |
|
1997 |
| Analysis of bothrojaracin content in the venom of an individual Bothrops jararaca snake collected over ten months |
|
1996 |
| Seasonal pattern of bothrojaracin isoforms produced by individual Bothrops jararaca (jararaca) snakes |
|
1996 |
| Purification of bothrojaracin in individual Bothrops jararaca snake venoms |
|
1995 |
| Análise da presença de botrojaracina - um inibidor prtéico isolado do veneno de Bothrops jararaca - em venenos individuais |
|
1994 |
| Variation in the individual composition of Bothrops jararaca snake venom |
|
1993 |
| Variabilidade quali-quantitativa da composição dos venenos da espécie Bothrops jararaca |
|
1992 |
